Validity and reliability of the Berlin questionnaire for the detection of moderate or severe obstructive sleep apnea in patients aged 40 years or older detected from primary care.
Berlin questionnaire
home respiratory polygraphy
obstructive sleep apnea
primary care
questionnaire
reliability
screening
validity
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2023
2023
Historique:
received:
27
05
2023
accepted:
21
07
2023
medline:
30
8
2023
pubmed:
30
8
2023
entrez:
30
8
2023
Statut:
epublish
Résumé
The obstructive sleep apnea syndrome (OSA) is a highly prevalent condition. In Spain and other countries, only 5%-9% of patients with OSA have been diagnosed and treated. The lack of accessibility to diagnosis is considered the main cause of this situation through easy-to-use screening instruments, it is necessary to check their validity and reliability in the context where they are to be used. To validate the Spanish translation of the Berlin questionnaire for screening for moderate or severe OSA in patients aged 40 years or more detected in primary care. A descriptive observational study, with a first qualitative phase of transcultural adaptation to Spanish using the translation-back-translation method. Setting: primary care level of the Spanish National Health System. A total of 255 patients recruited from 7 healthcare centers completed the study. The Berlin questionnaire was administered to the recruited patients, and subsequently, a respiratory polygraphy was performed to confirm the diagnosis of OSA. The concurrent criterion validity of the questionnaire and its reliability in terms of internal consistency and reproducibility (intra-observer agreement) were analyzed. The patients' mean age was 54.76 years (SD: 6.57; 95% CI: 53.53-54.99), and 54.12% were men (95% CI: 47.96-60.27). We found that 61.57% (95% CI: 55.57-67.57) presented OSA (apnea-hypopnea index-AHI >5), and 45.5% (95% CI: 17.05-57.92) presented moderate or severe (AHI >15) OSA. The Berlin questionnaire, with a cut-off point of 4.5, showed a sensitivity of 76.77% (95% CI: 67.94-85.59), a specificity of 74.49% (95% CI: 65.35-83.63), a positive predictive value of 75.25% (95% CI: 66.34-84.16), a negative predictive value of 76.04% (95% CI: 66.98-85.10), and an area under the curve of 0.786 (95% CI: 0.721-0.851). Cronbach's alpha coefficient was 0.730 (95% CI: 0.668-0.784), and the Kappa index was 0.739 (95% CI, 0.384-1.000). The Spanish adaptation of the Berlin questionnaire has good validity and reliability as a test for the diagnostic screening of moderate or severe OSA in patients aged 40 years or older. The findings of our study confirm that primary care physicians should use such screening tools to predict OSA.
Sections du résumé
Background
UNASSIGNED
The obstructive sleep apnea syndrome (OSA) is a highly prevalent condition. In Spain and other countries, only 5%-9% of patients with OSA have been diagnosed and treated. The lack of accessibility to diagnosis is considered the main cause of this situation through easy-to-use screening instruments, it is necessary to check their validity and reliability in the context where they are to be used.
Objective
UNASSIGNED
To validate the Spanish translation of the Berlin questionnaire for screening for moderate or severe OSA in patients aged 40 years or more detected in primary care.
Methods
UNASSIGNED
A descriptive observational study, with a first qualitative phase of transcultural adaptation to Spanish using the translation-back-translation method. Setting: primary care level of the Spanish National Health System. A total of 255 patients recruited from 7 healthcare centers completed the study. The Berlin questionnaire was administered to the recruited patients, and subsequently, a respiratory polygraphy was performed to confirm the diagnosis of OSA. The concurrent criterion validity of the questionnaire and its reliability in terms of internal consistency and reproducibility (intra-observer agreement) were analyzed.
Results
UNASSIGNED
The patients' mean age was 54.76 years (SD: 6.57; 95% CI: 53.53-54.99), and 54.12% were men (95% CI: 47.96-60.27). We found that 61.57% (95% CI: 55.57-67.57) presented OSA (apnea-hypopnea index-AHI >5), and 45.5% (95% CI: 17.05-57.92) presented moderate or severe (AHI >15) OSA. The Berlin questionnaire, with a cut-off point of 4.5, showed a sensitivity of 76.77% (95% CI: 67.94-85.59), a specificity of 74.49% (95% CI: 65.35-83.63), a positive predictive value of 75.25% (95% CI: 66.34-84.16), a negative predictive value of 76.04% (95% CI: 66.98-85.10), and an area under the curve of 0.786 (95% CI: 0.721-0.851). Cronbach's alpha coefficient was 0.730 (95% CI: 0.668-0.784), and the Kappa index was 0.739 (95% CI, 0.384-1.000).
Conclusion
UNASSIGNED
The Spanish adaptation of the Berlin questionnaire has good validity and reliability as a test for the diagnostic screening of moderate or severe OSA in patients aged 40 years or older. The findings of our study confirm that primary care physicians should use such screening tools to predict OSA.
Identifiants
pubmed: 37644989
doi: 10.3389/fmed.2023.1229972
pmc: PMC10461081
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1229972Informations de copyright
Copyright © 2023 Navarrete-Martínez, Muñoz-Gómez, Serrano-Merino, Perula-de Torres, Vaquero-Abellán, Silva-Gil, Roldán-Villalobos, Martín-Rioboó, Ruiz-Moruno, Romero-Rodríguez, González-Lama and Montes-Redondo.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Eval Clin Pract. 2011 Apr;17(2):268-74
pubmed: 20874835
Arch Bronconeumol. 1997 Feb;33(2):69-73
pubmed: 9091116
Am J Respir Crit Care Med. 2004 Mar 15;169(6):666-7
pubmed: 15003949
J Am Med Dir Assoc. 2009 Mar;10(3):207-10
pubmed: 19233062
Arch Bronconeumol. 2004 Jun;40(6):259-67
pubmed: 15161592
BMC Pulm Med. 2013 Jan 24;13:6
pubmed: 23347772
Lancet Respir Med. 2019 Aug;7(8):687-698
pubmed: 31300334
Front Public Health. 2022 Sep 09;10:975114
pubmed: 36159274
Stroke. 2006 Sep;37(9):2317-21
pubmed: 16888274
Sleep Med Rev. 2017 Dec;36:57-70
pubmed: 27919588
Oman Med J. 2018 May;33(3):184-192
pubmed: 29896325
Arch Bronconeumol. 2011 Mar;47(3):143-56
pubmed: 21398016
Gac Sanit. 2019 Sep - Oct;33(5):421-426
pubmed: 30033095
Can J Anaesth. 2010 May;57(5):423-38
pubmed: 20143278
Am J Epidemiol. 2001 Jul 1;154(1):50-9
pubmed: 11434366
Arch Intern Med. 2008 Feb 11;168(3):297-301
pubmed: 18268171
Arch Bronconeumol. 2022 Jan;58(1):52-68
pubmed: 33875282
Aten Primaria. 2002 Apr 15;29(6):378-84
pubmed: 11996720
Dan Med J. 2018 Sep;65(9):
pubmed: 30187861
Eur Respir J. 2017 Jan 18;49(1):
pubmed: 28100549
Ann Intern Med. 1999 Oct 5;131(7):485-91
pubmed: 10507956
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571